USCAP Modern Breast Pathology Practical Updates from the International Society of Breast Pathology (ISBP) 2026
USCAP Modern Breast Pathology Practical Updates from the International Society of Breast Pathology (ISBP) 2026
Couldn't load pickup availability
USCAP Modern Breast Pathology Practical Updates from the International Society of Breast Pathology (ISBP) 2026
-
Share positive thoughts and feedback from your customer.
Author -
Share positive thoughts and feedback from your customer.
Author -
Share positive thoughts and feedback from your customer.
Author
USCAP Modern Breast Pathology Practical Updates from the International Society of Breast Pathology (ISBP) 2026
Modern Breast Pathology 2026
Practical Updates & WHO Classification Insights
π¦ Product Details
- Format: 19 Videos + 19 Subtitles (.vtt) + 26 PDFs 9.5 GB
- Release Date: April 8, 2026
- Access: On-demand
- Level: Advanced / Diagnostic Practice
π©Ί Program Overview
The USCAP Modern Breast Pathology 2026 course, developed in collaboration with the International Society of Breast Pathology (ISBP), delivers a comprehensive, evidence-based update on breast pathology.
This program focuses on the latest WHO 6th edition classification updates, biomarker testing advancements, and real-world diagnostic challenges, helping pathologists refine their interpretation of breast lesionsβfrom benign mimics to complex malignancies.
Designed with a strong practical approach, this course emphasizes accurate diagnosis, clinical correlation, and improved patient management.
π― Key Features
- Expert-led lectures from global leaders in breast pathology
- Focused update on WHO Breast Tumor Classification (6th Edition)
- Case-based learning with diagnostic pitfalls and mimics
- Comprehensive biomarker and molecular pathology updates
- Includes subtitles and downloadable PDFs
π What You Will Learn
- Recognize and resolve challenging diagnostic cases in breast pathology
- Apply updated WHO classification and ISBP consensus guidelines
- Interpret biomarker testing for clinical decision-making
- Differentiate benign vs malignant lesions and histologic mimics
- Utilize immunohistochemistry effectively in diagnosis
- Integrate molecular pathology into routine practice
π§© Core Topics Covered
π¬ Classification & Diagnostic Framework
- WHO Classification of Breast Tumors (6th Edition)
- Special type carcinomas and lobular carcinoma updates
- Fibroepithelial and papillary lesions
π§ͺ Molecular & Biomarker Testing
- Current biomarker testing standards
- Role of precision medicine in breast cancer
- Integration of molecular findings into pathology reports
β οΈ Diagnostic Pitfalls & Challenging Cases
- Unusual mimickers of malignancy
- Spindle cell lesions and small glandular proliferations
- Atypical intraductal proliferations
π§« Specimen Evaluation & Clinical Correlation
- Assessment after neoadjuvant therapy
- Targeted use of immunohistochemistry
- Correlation with surgical and oncologic management
π§ Learning Approach
- Case-based discussions
- Real diagnostic scenarios
- Panel discussions with expert insights
- Practical interpretation strategies
π¨ββοΈ Target Audience
- Practicing pathologists (academic & community)
- Pathology residents and fellows
- Cytopathologists
- Breast oncologists and surgeons
- Researchers in breast cancer
π Why This Course Stands Out
- Focused on real-world diagnostic challenges
- Updated with latest WHO classification (6th Edition)
- Combines histopathology + molecular insights
- Designed for immediate clinical application
- Delivered by leading experts in breast pathology worldwide
- Updates from the WHO Classification of Breast Tumors, 6th Edition β Puay Hoon Tan, MD, MBBS, FRCPA, FRCPath
- Classification of Special Type Carcinomas β Hannah Y. Wen, MD, PhD
- Unusual Mimickers and Diagnostic Pitfalls β Ashley M. Cimino-Mathews, MD
- Assessment of Breast Specimens After Neoadjuvant Therapy β Popi Siziopikou, MD, PhD
- Special Type Carcinomas β Hannah Y. Wen, MD, PhD
- Unusual Mimickers β Ashley M. Cimino-Mathews, MD
- The Ever-Changing Field of Biomarker Testing β Hannah Y. Wen, MD, PhD
- Challenging Papillary Lesions β Marina De Brot, MD, PhD
- Pitfalls in Spindle Cell Lesions β Ashley M. Cimino-Mathews, MD
- Small Glandular Proliferations β Benjamin C. Calhoun, MD, PhD
- Challenging Papillary Lesions β Marina De Brot, MD, PhD
- Small Glandular Proliferations- Benjamin C. Calhoun, MD, PhD
- Updates in the Classification of Lobular Carcinoma β Benjamin C. Calhoun, MD, PhD
- Targeted Use of Immunohistochemistry in Breast Pathology Diagnoses β Marina De Brot, MD, PhD
- Atypical Intraductal Proliferations β Popi Siziopikou, MD, PhD
- Fibroepithelial Lesions β Puay Hoon Tan, MD, MBBS, FRCPA, FRCPath
- Atypical Intraductal Proliferations β Popi Siziopikou, MD, PhD
- Fibroepithelial Lesions β Puay Hoon Tan, MD, MBBS, FRCPA, FRCPath
- FREE SECTION: Panel Discussions
